Riskpilot← Back to searchSign inGet full accessEuropharma AB
ABActiveOrg 5567482301Ringtonsgränden 6Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20080 employees
Revenue 2025
SEK 0
EBITDA margin
—
Equity ratio
25.3%
Financial strength
Net profit 2025
SEK 0
-100% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | — | — |
| Net profit | SEK 0 | -100% |
| Total assets | SEK 414K | +210% |
| Equity | SEK 105K | +0% |
| Employees | 0 | — |
Legal name
Europharma AB
Org number
5567482301
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
3 januari 2008
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva konsultation och tillhandahålla tjänster, tillverkning, import och export, handel och distribution av produkter inom läkemedel, hälsovård, sjukvård, friskvård, medicinska produkter och utrustning samt därmed förenlig verksamhet.
Address
Ringtonsgränden 6
Email
mw@minglo.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 33 | 0 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | — | — | — | — | — | — | — | −1 | 33 | — |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | — | — | — |
| EBIT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −1 | 33 | 0 |
| Net financials | — | — | — | — | — | — | — | — | — | — |
| Profit before tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −1 | 33 | 0 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | — | −1 | — |
| Net profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −1 | 32 | 0 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 4 | 4 | 4 | 4 | 74 | 74 | 74 | 73 | 134 | 414 |
| Equity | 4 | 4 | 4 | 4 | 74 | 74 | 74 | 73 | 105 | 105 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — |
| Short-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | 29 | 309 |
| Total debt | — | — | — | — | — | — | — | — | 29 | 309 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20162025
Equity ratio
25.3%
This company
38.2%
Market median
-34% vs market
20162025
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20162025
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20162025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20162025
Debt / equity
2.96×
This company
0.62×
Market median
-377% vs market
20162025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-07-01 – 2016-06-30
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Deputy Board Member | 2025 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Europharma AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Mikael Werner | Board of Directors | 0 companies |
| Carl Oscar Leo Werner | Deputy Board Member | 0 companies |
| Dominik Czajkowski | Deputy Board Member | 0 companies |